chr6-53498978-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001498.4(GCLC):​c.1703-11C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00234 in 1,581,032 control chromosomes in the GnomAD database, including 107 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 97 hom. )

Consequence

GCLC
NM_001498.4 intron

Scores

2
Splicing: ADA: 0.0002752
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.02

Publications

2 publications found
Variant links:
Genes affected
GCLC (HGNC:4311): (glutamate-cysteine ligase catalytic subunit) Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.[provided by RefSeq, Oct 2010]
GCLC-AS1 (HGNC:56649): (GCLC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 6-53498978-G-C is Benign according to our data. Variant chr6-53498978-G-C is described in ClinVar as Benign. ClinVar VariationId is 811041.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0586 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001498.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GCLC
NM_001498.4
MANE Select
c.1703-11C>G
intron
N/ANP_001489.1P48506
GCLC
NM_001197115.2
c.1589-11C>G
intron
N/ANP_001184044.1E1CEI4
GCLC-AS1
NR_183318.1
n.327-7176G>C
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GCLC
ENST00000650454.1
MANE Select
c.1703-11C>G
intron
N/AENSP00000497574.1P48506
GCLC
ENST00000616923.5
TSL:1
c.1544-11C>G
intron
N/AENSP00000482756.2B4E2I4
GCLC
ENST00000515580.1
TSL:1
n.1307-11C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00272
AC:
411
AN:
151226
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000535
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.0641
Gnomad SAS
AF:
0.00209
Gnomad FIN
AF:
0.0000972
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000295
Gnomad OTH
AF:
0.00384
GnomAD2 exomes
AF:
0.00603
AC:
1478
AN:
245266
AF XY:
0.00554
show subpopulations
Gnomad AFR exome
AF:
0.000868
Gnomad AMR exome
AF:
0.000204
Gnomad ASJ exome
AF:
0.000807
Gnomad EAS exome
AF:
0.0741
Gnomad FIN exome
AF:
0.0000466
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.00183
GnomAD4 exome
AF:
0.00230
AC:
3292
AN:
1429688
Hom.:
97
Cov.:
27
AF XY:
0.00226
AC XY:
1613
AN XY:
712754
show subpopulations
African (AFR)
AF:
0.000367
AC:
12
AN:
32724
American (AMR)
AF:
0.000225
AC:
10
AN:
44414
Ashkenazi Jewish (ASJ)
AF:
0.000775
AC:
20
AN:
25816
East Asian (EAS)
AF:
0.0638
AC:
2523
AN:
39530
South Asian (SAS)
AF:
0.00191
AC:
162
AN:
85036
European-Finnish (FIN)
AF:
0.000356
AC:
19
AN:
53306
Middle Eastern (MID)
AF:
0.000528
AC:
3
AN:
5686
European-Non Finnish (NFE)
AF:
0.000237
AC:
257
AN:
1083958
Other (OTH)
AF:
0.00483
AC:
286
AN:
59218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
171
342
512
683
854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00272
AC:
411
AN:
151344
Hom.:
10
Cov.:
32
AF XY:
0.00286
AC XY:
211
AN XY:
73888
show subpopulations
African (AFR)
AF:
0.000533
AC:
22
AN:
41264
American (AMR)
AF:
0.00105
AC:
16
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.0643
AC:
333
AN:
5180
South Asian (SAS)
AF:
0.00209
AC:
10
AN:
4784
European-Finnish (FIN)
AF:
0.0000972
AC:
1
AN:
10286
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000295
AC:
20
AN:
67818
Other (OTH)
AF:
0.00380
AC:
8
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000898
Hom.:
2
Bravo
AF:
0.00321

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.021
DANN
Benign
0.32
PhyloP100
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00028
dbscSNV1_RF
Benign
0.040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066507; hg19: chr6-53363776; API